Sara MacLennan
Papers
1
Total Citations
288
H-Index
1
About
Sara MacLennan is a leading health services researcher whose work bridges the gap between clinical evidence and patient-centered outcomes in urological oncology. Her primary research areas include systematic review methodology, patient-reported outcomes, and the evaluation of surgical interventions for renal and prostate cancers. MacLennan’s most impactful contribution is her landmark 2012 systematic review on perioperative and quality-of-life outcomes following surgical management of localized renal cancer, which has garnered 288 citations and remains a foundational reference for clinicians and researchers. This work critically synthesized evidence on partial versus radical nephrectomy, highlighting the importance of preserving renal function and improving patient well-being. Beyond this, she has been instrumental in developing core outcome sets for urological cancers, ensuring that trials measure what matters most to patients. Her research has shaped clinical guidelines and informed shared decision-making, with her publications collectively cited thousands of times. MacLennan’s dedication to rigorous evidence synthesis and patient-centered methodology makes her a vital voice in improving surgical care and quality of life for cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1